Music Interventions for Dementia and Depression in Elderly Care

NCT03496675 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1021

Last updated 2025-07-09

No results posted yet for this study

Summary

This study evaluates the effectiveness of two music-based approaches - group music therapy and recreational choir singing - for reducing depression symptoms in people living with dementia. It also examines mechanisms and heterogeneity of treatment effects.

Conditions

Interventions

BEHAVIORAL

Group Music Therapy

The core intention of GMT is to meet the psychosocial needs of each person living with dementia, which in turn is thought to reduce depressive symptoms and anxiety and to stimulate overall social and emotional wellbeing. It includes active, reciprocal music making with the use of singing and musical instruments. GMT is provided by a trained music therapist, highly skilled as a musician, and registered with the appropriate professional association in his or her country.

BEHAVIORAL

Recreational Choir Singing

RCS is intended to foster connectedness in a group, wellbeing, and enjoyment of music making in a group. It includes singing familiar songs and providing a familiar musical environment for participants. RCS is provided by a musician with choir leading skills.

OTHER

Standard care

May include pharmacological and non-pharmacological interventions as locally available

Sponsors & Collaborators

  • University of Melbourne

    collaborator OTHER
  • University of Oldenburg

    collaborator OTHER
  • University Medical Center Groningen

    collaborator OTHER
  • Ankara Haci Bayram Veli University

    collaborator UNKNOWN
  • University of Nottingham

    collaborator OTHER
  • NORCE Norwegian Research Centre AS

    lead OTHER

Principal Investigators

  • Vigdis Sveinsdottir, PhD · GAMUT, NORCE Norwegian Research Centre, Bergen, Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-18
Primary Completion
2023-09-29
Completion
2023-09-29

Countries

  • Australia
  • Germany
  • Netherlands
  • Norway
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03496675 on ClinicalTrials.gov